Skip to main content

Bag This Bargain Even Cheaper Than Director Coleman Did

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on May 12, Axsome Therapeutics Inc's Director, Mark Coleman, invested $29,075.00 into 500 shares of AXSM, for a cost per share of $58.15..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.